Boucenna, A., A. Hirech, R. M. Larbi, and D. Satta. “Impact of CYP2D6 Polymorphisms in Predicting Occurrence of Adverse Effect to Tamoxifen and Developing Recurrence in ER+ Breast Cancer Patients”. Archives of Breast Cancer, vol. 11, no. 4, Oct. 2024, doi:10.32768/abc.2024114392-399.